Company news
Spectral Medical Inc (TSX:EDT) news
Spectral Medical Inc news releases on 6ix. Latest, Jul 25, 2014: Spectral Diagnostics and Toray Industries announce closing of Tranche "A" component of its up…
Press releases — page 2
Spectral Diagnostics and Toray Industries announce closing of Tranche "A" component of its up to $18.2 million Offering
July 25, 2014
Spectral Diagnostics announces shareholder approval of its up to $18.2 million offering
July 22, 2014
Spectral Announces ISS and Glass Lewis Recommendations to Vote in Favour of its up to $18.2 Million Offering
July 8, 2014
Spectral Diagnostics announces Proposed Offering of up to $18.2 million
June 11, 2014
U.S. FDA Approves Spectral's Amended Protocol for its EUPHRATES Trial
June 3, 2014
Spectral announces first quarter, 2014 results
May 15, 2014
Spectral Diagnostics provides update on results of annual and special meeting of shareholders
May 6, 2014
Spectral Diagnostics Announces Leading Independent Proxy Firms Recommend Spectral Shareholders Vote For Name Change and For Amendment of Warrants
April 21, 2014
Spectral Updates Status Of EUPHRATES Trial
April 14, 2014
Spectral announces fourth quarter and fiscal 2013 results
March 27, 2014
Spectral Diagnostics Provides Clinical Update on the Euphrates Trial
March 11, 2014
Spectral Diagnostics Announces Extension of Warrants
February 24, 2014
Spectral announces status of second interim analysis
January 28, 2014
Spectral Announces Third Quarter 2013 Results
November 13, 2013
Spectral Reaches Enrollment Milestone for its Phase III Euphrates Trial
September 26, 2013
Spectral announces second quarter 2013 results
August 13, 2013
Spectral to present at Wedbush Life Sciences Conference
August 1, 2013
Spectral provides update on its EUPHRATES trial
July 31, 2013
Spectral Diagnostics Announces Board Changes
July 26, 2013
Spectral Diagnostics provides update on results of annual and special meeting
May 22, 2013
Spectral announces first quarter 2013 results
May 15, 2013
Spectral Appoints Vice President of Sales and Marketing
May 7, 2013
Spectral Diagnostics adopts new By-Laws which contain advance notice provisions
April 16, 2013
Spectral Diagnostics Closes $5.6 Million Offering
April 2, 2013
Spectral announces fourth quarter and fiscal 2012 results
March 27, 2013
Spectral Diagnostics increases offering to $5.6 million
March 18, 2013
Toray Industries makes $5 million strategic investment in Spectral Diagnostics
March 7, 2013
Spectral announces results of first interim analysis by Data Safety and Monitoring Board
February 4, 2013
Spectral Announces Enrollment Milestone for its EUPHRATES Trial
December 5, 2012
Spectral announces third quarter 2012 results
November 14, 2012
Spectral announces new clinical data is being presented at international sepsis forum
November 9, 2012
FDA Approves Spectral's Amended Protocol for its Euphrates Trial
September 26, 2012
Spectral to present at Rodman & Renshaw Annual Global Investment Conference on September 10
September 4, 2012
Spectral and Toray expand EAA(tm)/ PMX Theranostic to Saudi Arabia and Turkey
August 16, 2012
Spectral Announces Second Quarter 2012 Results
August 14, 2012
Spectral Diagnostics Provides Update on Euphrates Trial
June 20, 2012
Spectral Diagnostics to Present at Bloom Burton & Co. Healthcare Investor Conference
June 12, 2012
Spectral Diagnostics to present at BioFinance 2012
May 17, 2012
Spectral Announces First Quarter 2012 Results
May 15, 2012
Spectral announces fourth quarter and 2011 results
March 16, 2012
Spectral begins trading on OTCQX
January 11, 2012
Spectral Diagnostics provides corporate update
January 4, 2012
Spectral Diagnostics Inc. announces normal course issuer bid
November 11, 2011
Spectral Announces Third Quarter Results
November 10, 2011
Spectral to Expand its Phase III Sepsis Trial to Canadian Sites
October 25, 2011
Spectral's Endotoxin Activity Assay featured in major publication
September 28, 2011
Spectral to present at Rodman & Renshaw Annual Global Investment Conference on September 13
September 6, 2011
Spectral Shareholders Approve Previously Announced $10 Million Private Placement
August 26, 2011
Spectral Diagnostics Announces Leading Independent Proxy Firms Recommend Spectral Shareholders Vote for the Proposed Private Placement of Spectral Shares to Medwell Capital Corp.
August 16, 2011
Spectral Announces Second Quarter Results
August 11, 2011